Healthcare Industry News: HIV/AIDS

Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes

Source: Mylan

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!